drugset / Trial / NCT02700815
Capsaicin + Diclofenac Gel in Acute Back Pain or Neck Pain
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomised, controlled multi-centre parallel group trial will assess the efficacy and tolerability of a topical formulation gel of the combination of diclofenac and capsaicin in comparison to gels with diclofenac alone, capsaicin alone, and placebo for the treatment of acute back pain or neck pain
Timeline
- Start
- 2016-05-09
- Primary completion
- 2017-07-13
- Completion
- 2017-07-21
Outcome
Met primary endpoint
registry Placebo Gel vs Diclofenac (2%) +Capsaicin (0.075%) Gel; p = 0.0303; Mean Difference (Net) -0.60 (95% CI -1.15 to -0.06) NCT02700815 ↗
paper demonstrates superiority of the combination (- 3.05 cm) versus diclofenac alone (- 2.33 cm) and placebo (- 2.45 cm). PMID 32221866 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capsaicin | Small molecule | 0.075 % | Topical |
| Subject | Diclofenac | Other / unclassified | 2 % | Topical |
Indications
No indication recorded.